References
- Cosío BG, Dacal D, Pérez de Llano L. Asthma–COPD overlap: Identification and optimal treatment. Therapeutic Advances in Respiratory Disease. 2018;12: 1–11.
- Seitz AE, Olivier KN, Adjemian J, Holland SM, Prevots R. Trends in bronchiectasis among Medicare beneficiaries in the United States, 2000 to 2007. Chest 2012;142: 432–439.10.1378/chest.11-220922302301
- Padilla-Galo A, Olveira C, Fernández de Rota-Garcia L, Marco-Galve I, Plata AJ, Alvarez A, et al. Factors associated with bronchiectasis in patients with uncontrolled asthma; the NOPES score: A study in 398 patients. Respiratory Research 2018;19: 43.10.1186/s12931-018-0746-7
- Kang HR, Choi GS, Park SJ, Song YK, Kim JM, Ha J, et al. The effects of bronchiectasis on asthma exacerbations. Tuberculosis and Respiratory Diseases. 2014;77(5): 209–214.10.4046/trd.2014.77.5.209
- Lynch DA, Newell JD, Tschomper BA, Cink TM, Newman LS, Bethel R. Uncomplicated asthma in adults: Comparison of CT appearance of the lungs in asthmatic and healthy subjects. Radiology. 1993;188(3): 829–833.10.1148/radiology.188.3.83513578351357
- Martínez-García MA, de la Rosa Carrillo D, Soler-Cataluña JJ, Donat-Sanz Y, Serra PC, Lerma MA, et al. Prognostic value of bronchiectasis in patients with moderate-to-severe chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine 2013;187(8): 823–831.10.1164/rccm.201208-1518OC23392438
- Agusti A, Calverley PM, Celli B, Coxson HO, Edwards LD, Lomas DA, et al. Characterisation of COPD heterogeneity in the ECLIPSE cohort. Respiratory Research 2010;11: 122.10.1186/1465-9921-11-12220831787
- Stewart JL, Maselli DJ, Anzueto A, Criner GJ, Han MK, Martinez FJ, et al. Clinical impact of CT radiological feature of bronchiectasis in the COPDgene cohort. American Journal of Respiratory and Critical Care Medicine 2012;185(Suppl.): A3656.
- Redondo M, Keyt H, Dhar R, Chalmers JD. Global impact of bronchiectasis and cystic fibrosis. Breathe 2016;12: 222–235.10.1183/20734735.00751628210295
- Vogelmeier CF, Criner GJ, Martinez FJ, Anzueto A, Barnes PJ, Bourbeau J, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report: GOLD executive summary. Archivos de Bronconeumología. 2017;53: 128–149.10.1016/j.arbr.2017.02.00128274597
- Miravitlles M, Soler-Cataluna JJ, Calle M, Molina J, Almagro P, Quintano JA, et al. Spanish guidelines for management of chronic obstructive pulmonary disease (GesEPOC) 2017. Pharmacological treatment of stable phase. Archivos de Bronconeumología 2017;53: 324–335.2847795410.1016/j.arbr.2017.03.017
- Miravitlles M, Alvarez-Gutierrez FJ, Calle M, Casanova C, Cosio BG, López-Viña A, et al. Algorithm for identification of asthma-COPD overlap: Consensus between the Spanish COPD and asthma guidelines. European Respiratory Journal 2017;49: 1700068.10.1183/13993003.00068-2017
- de Marco R, Marcon A, Rossi A, Antó JM, Cerveri I, Gislason T, et al. Asthma, COPD and overlap syndrome: A longitudinal study in young European adults. European Respiratory Journal 2015;46: 671–679.10.1183/09031936.00008615
- Tommola M, Ilmarinen P, Tuomisto LE, Lehtimäki L, Haanpää J, Niemelä O, et al. Differences between asthma–COPD overlap syndrome and adult-onset asthma. European Respiratory Journal 2017;49: 1–10.
- Zeki A, Schivo M, Chan A, Albertson TE, Louie S. The asthma-COPD overlap syndrome: A common clinical problem in the elderly. Journal of Allergy 2011;861926: 10.
- Ferri S, Sorrentino R, Chessari C, Terranova G, Augelletti T, Campisi R, et al. Bronchiectasis: Understanding the phenotype. European Respiratory Journal. 2017;50: PA3594.
- Badawy MS, Rashaad A, Mohamed R. Evaluation of co-morbidities among different chronic obstructive pulmonary disease phenotypes European Respiratory Journal. 2018;52: PA4031.
- Chalmers JD. Editorial-new insights into the epidemiology of bronchiectasis. Chest 2018;154(6): 1272–1273.10.1016/j.chest.2018.08.1051
- Sadigov A, Isayev I, Aliyev A. C24 [92] exacerbation rate of non-cystic fibrosis bronchiectasis in patients with asthma-COPD overlap syndrome. Abstract Book. 2nd World Bronchiectasis Conference, Milan 6–8 July 2017 p.127.
- Zatloukal J, Volakova E, Koblizek VL, Svoboda M, Popelkova P, Plutinsky M, et al. Effect on the rate of COPD exacerbations. Phenotype-based therapy of COPD. European Respiratory Journal 2018;52: PA3860.
- Brode SK, Campitelli MA, Kwong JC, Lu H, Marchand-Austin A, Gershon AS, et al. The risk of mycobacterial infections associated with inhaled corticosteroid use. European Respiratory Journal 2017;50: 1700037.10.1183/13993003.00037-2017
- Cordova-Rivera L, Gibson PG, Gardiner PA, McDonald VM. Physical activity associates with disease characteristics of severe asthma, bronchiectasis and COPD. Respirology 2019;24(4): 352–360.3038439610.1111/resp.13428
- McDonald VM, Higgins I, Wood LG, Gibson PG. Multidimensional assessment and tailored interventions for COPD: Respiratory utopia or common sense? Thorax. 2013;68: 691–694.2350362410.1136/thoraxjnl-2012-202646
- Diaz-Guzman E, Khosravi M, Mannino DM. Asthma, chronic obstructive pulmonary disease, and mortality in the U.S. population. COPD 2011;8(6): 400–407.
- Agusti A, Bel E, Thomas M, Vogelmeier C, Brusselle G, Holgate S, et al. Treatable traits: Toward precision medicine of chronic airway diseases. European Respiratory Journal 2016;47: 410–419.10.1183/13993003.01359-2015
- Hurst JR, Elborn JS, De Soyza A. COPD-bronchiectasis overlap syndrome. European Respiratory Journal. 2015;45: 310–313.10.1183/09031936.00170014
- Sanjay H. Chotirmall-future directions: The next 10 years in research. Bronchiectasis 2018 (chapter), doi:10.1183/2312508X. 10017217 ISBN (electronic): 978-1-84984-098-9.